Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jay Levy currently holds 13,800 shares of UNIGENE LABORATORIES INC (UGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay Levy has been a net neutral trader of UGNE stock. They have purchased $0 and sold $0 worth of shares.
Jay Levy's most recent insider trade was on Feb 4, 2010, when they sold 283,246 shares at $0.00 per share.
Jay Levy serves as Executive at UNIGENE LABORATORIES INC (UGNE). They have executed 8 insider transactions totaling $0 over their tenure at the company.
Jay Levy holds the position of Executive at UNIGENE LABORATORIES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Jay Levy has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jay Levy was on Oct 19, 2009, when they sold $12.6K worth of UGNE shares. This transaction involved 20,000 shares at $0.63 per share.
Jay Levy currently owns 13,800 shares of UNIGENE LABORATORIES INC (UGNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jay Levy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jay Levy has 8 Form 4 filings on record as an insider at UNIGENE LABORATORIES INC.
Set alerts for Jay Levy and 40,000+ other insiders.